UBS Equities-US Equity Strategy _Earnings Brief 1Q24 May 31_ Golub-108467990
Global Research and Evidence Lab Earnings Brief 1Q24: May 31 2Q EPS is expected to grow 10.5%, versus 10.7% in 1Q. Notably, from this point last
Global Research and Evidence Lab Earnings Brief 1Q24: May 31 2Q EPS is expected to grow 10.5%, versus 10.7% in 1Q. Notably, from this point last
Global Research and Evidence Lab Earnings Brief 1Q24: May 31 2Q EPS is expected to grow 10.5%, versus 10.7% in 1Q. Notably, from this point last
Global Research and Evidence Lab Earnings Brief 1Q24: May 31 2Q EPS is expected to grow 10.5%, versus 10.7% in 1Q. Notably, from this point last核心数据:2Q EPS is expected to grow 10.5%, versus 10.7% in 1Q. Notably, from this point last;similarly, EPS growth would come in at 16.5%.;In 1Q, TECH+ EPS grew 40.2%, versus 1.3% for the rest of the market. In 2Q, TECH+ is。
覆盖 2024 年,全文约 18。
本报告免费查阅,登录资料宝后即可在线获取完整内容。
适合战略规划、行业研究员等读者参考。
重点分析了REITs等议题。